These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28393205)

  • 21. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.
    Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinesin Motor Protein KIFC1 Is a Target Protein of miR-338-3p and Is Associated With Poor Prognosis and Progression of Renal Cell Carcinoma.
    Li G; Chong T; Yang J; Li H; Chen H
    Oncol Res; 2018 Dec; 27(1):125-137. PubMed ID: 29562961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling.
    Wang J; Zhang Y; Liu X; Ma J; Liu P; Hu C; Zhang G
    Oncol Rep; 2014 Dec; 32(6):2557-63. PubMed ID: 25323007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
    Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
    Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
    Zhao Q; Xu L; Sun X; Zhang K; Shen H; Tian Y; Sun F; Li Y
    Tumour Biol; 2017 Jun; 39(6):1010428317707881. PubMed ID: 28653875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
    Meng K; Li Z; Cui X
    J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.
    Ma Y; Zhang H; He X; Song H; Qiang Y; Li Y; Gao J; Wang Z
    Tumour Biol; 2015 Nov; 36(11):8389-98. PubMed ID: 26018509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma.
    Miao C; Liang C; Tian Y; Xu A; Zhu J; Zhao K; Zhang J; Hua Y; Liu S; Dong H; Zhang C; Su S; Li P; Qin C; Wang Z
    Oncotarget; 2017 Nov; 8(58):97811-97821. PubMed ID: 29228653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
    Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.
    Lyu WJ; Shu YJ; Liu YB; Dong P
    Chin Med J (Engl); 2020 Oct; 133(19):2321-2329. PubMed ID: 32925281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
    Ning L; Li Z; Wei D; Chen H; Yang C
    Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.